From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
4,753 Search Results
Warning: Your search returned more than 1,000 results. Try narrowing your search by adding another term, such as a name, year, category or state. Sorting the record set in reverse alphabetical order by name may also allow you to see additional records.
You can use quotation marks — e.g. "John Doe" — to refine your search. By default, search results are sorted to display closest matching names first.
Click on a name to see payment details. Important notes about this list »
|Name / Payee||City||State||Company||Year||Category||Amount|
|HOWARD S LAZARUS »||NEW ALBANY||Ind.||GlaxoSmithKline||2013||Research||$4,759|
|KIMBERLY LAZARUS » ↳ Payee: DYNAMED CLINICAL RESEARCH LP||HOUSTON||Texas||GlaxoSmithKline||2013||Research||$28,138|
|KIMBERLY LAZARUS » ↳ Payee: DYNAMED CLINICAL RESEARCH LP||HOUSTON||Texas||GlaxoSmithKline||2012||Research||$2,500|
|MARK MARK BAILEY »||BIRMINGHAM||Ala.||Pfizer||2011||Speaking||$1,300|
|R MARK MARK GHOBRIAL »||DUARTE||Calif.||Novartis||2012||Travel||$802|
|Mark Holm »||St. Cloud||Minn.||AstraZeneca||2010||Speaking||$7,990|
|Mark Belfer »||Indianapolis||Ind.||AstraZeneca||2010||Speaking||$1,650|
|Mark Bowling »||Madison||Miss.||AstraZeneca||2010||Speaking||$4,500|
|Mark Sands »||Metairie||La.||AstraZeneca||2010||Speaking||$9,550|
|Mark Livezey »||Lilburn||Ga.||AstraZeneca||2010||Speaking||$1,950|
|Mark Minor »||Melbourne||Fla.||AstraZeneca||2010||Speaking||$13,300|
|Mark Lebenthal »||Bridgewater||N.J.||AstraZeneca||2010||Speaking||$3,250|
|Mark Sweeny »||Crane Hill||Ala.||AstraZeneca||2010||Speaking||$52,170|
|Mark Ayad Matta »||New Castle||Pa.||AstraZeneca||2011||Speaking||$2,450|
|Mark Michael »||Cincinnati||Ohio||AstraZeneca||2011||Travel||$735|
|Mark J. Schlickman »||Worcester||Mass.||AstraZeneca||2011||Travel||$295|
|Mark L. Vandewalker »||Columbia||Mo.||AstraZeneca||2011||Speaking||$24,600|
|Mark A. Creager »||Boston||Mass.||AstraZeneca||2011||Consulting||$12,536|
|Mark Agulnik »||CHICAGO||Ill.||GlaxoSmithKline||2010||Consulting||$1,400|
|Mark Genovese »||PALO ALTO||Calif.||GlaxoSmithKline||2010||Speaking||$400|
|Mark Dransfield »||BIRMINGHAM||Ala.||GlaxoSmithKline||2010||Speaking||$8,400|
|Mark Lanasa »||DURHAM||N.C.||GlaxoSmithKline||2010||Speaking||$9,500|
|Mark Kaufmann »||NEW YORK||N.Y.||GlaxoSmithKline||2010||Speaking||$5,250|
|Mark Malek »||LOS ANGELES||Calif.||GlaxoSmithKline||2010||Speaking||$20,600|
|Mark Levis »||BALTIMORE||Md.||GlaxoSmithKline||2010||Consulting||$1,600|
Results sorted to display closest matching names first. Note that health providers may receive money from the many pharmaceutical companies that are not in our database.
Warning: Your search returned more than 1,000 results. Only the first 1,000 results have been returned.
ProPublica research, based on pharmaceutical company disclosures.
- Some records include both the practitioner listed by the company and the entity receiving payment. If only one name is listed, it represents both the listed practitioner and payee. For instance, some payments made to a university research lab will list the university as the entity receiving payment, and an individual researcher as the practitioner.
- Companies are continually updating their data, so the most recent additions may not be included in our database.
- A physician on the list may be getting money from other companies that have yet to disclose payments.
- Practitioner names and addresses (city/state) are listed as the companies released them and may vary. For instance, some companies include a middle initial, and others do not. Some companies also list different cities for the same individual. This may happen because professionals may have practices in multiple locations or because they provided different addresses for payment.